NCT06572826 Cardiac Rehabilitation in Patients Acutely Managed for Cardiogenic Shock (ENIGMA)
| NCT ID | NCT06572826 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Don Carlo Gnocchi Onlus |
| Condition | Cardiogenic Shock |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-08-31 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-08-31 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective and retrospective multicentre study conducted under the scientific coordination of the IRCCS Fondazione Don Gnocchi and funded by the Italian Ministry of Health (PNRR-MCNT2-2023-12377767). Using the Altshock registry, the largest multicentre Cardiogenic Shock (CS) registry in Italy, which currently has registered more than 1,000 CS patients across Italy, we will recruit patients to: (1) provide a granular assessment of post-acute phase programmes, patients' functional disability, return to work and quality of life, including specific reference to gender; (2) implement specific pathways of care in the post-acute phase; (3) provide a multidimensional assessment, thus validating an innovative model in comparison with the traditional pathway, defining the potential benefits to and impact on economic efficiency and the general sustainability of this therapeutic trajectory.
Eligibility Criteria
Inclusion Criteria: • All consecutive patients with a clinical diagnosis of Cardiogenic Shock. Exclusion Criteria: • Refusal to give informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06572826 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 110 Years, studying Cardiogenic Shock. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06572826 currently recruiting?
Yes, NCT06572826 is actively recruiting participants. Contact the research team at nmorici@dongnocchi.it for enrollment information.
Where is the NCT06572826 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06572826 clinical trial?
NCT06572826 is sponsored by Fondazione Don Carlo Gnocchi Onlus. The trial plans to enroll 2,000 participants.